↓ Skip to main content
Embed badge What is this page?

Adjuvant chemotherapy for endometrial cancer after hysterectomy

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

policy
1 policy source
twitter
3 tweeters
wikipedia
4 Wikipedia pages
f1000
1 research highlight platform

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
171 Mendeley

What is this page?

Summary Policy documents Twitter Wikipedia Research highlights Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjuvant chemotherapy for endometrial cancer after hysterectomy
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd003175.pub2
Pubmed ID
21975736
Authors

Nick Johnson, Andrew Bryant, Tracie Miles, Thomas Hogberg, Paul Cornes

Abstract

Endometrial adenocarcinoma (womb cancer) is a malignant growth of the lining (endometrium) of the womb (uterus). It is distinct from sarcomas (tumours of the uterine muscle). Survival depends the risk of microscopic metastases after surgery. Adjuvant (postoperative) chemotherapy improves survival from some other adenocarcinomas, and there is evidence that endometrial cancer is sensitive to cytotoxic therapy. This systematic review examines the effect of chemotherapy on survival after hysterectomy for endometrial cancer.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Egypt 1 <1%
Unknown 166 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 18%
Student > Bachelor 20 12%
Researcher 18 11%
Student > Ph. D. Student 14 8%
Student > Doctoral Student 12 7%
Other 33 19%
Unknown 44 26%
Readers by discipline Count As %
Medicine and Dentistry 76 44%
Nursing and Health Professions 16 9%
Agricultural and Biological Sciences 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Psychology 6 4%
Other 15 9%
Unknown 45 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#3,175,027
of 23,122,481 outputs
Outputs from Cochrane database of systematic reviews
#5,869
of 12,372 outputs
Outputs of similar age
#17,242
of 133,903 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 125 outputs
Altmetric has tracked 23,122,481 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,372 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.4. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 133,903 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.

This page is provided by Altmetric.